The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SOlar: A translational phase II study of single-agent olaparib in the treatment of advanced esophagogastric cancer.
 
Elizabeth Cartwright
No Relationships to Disclose
 
Caroline Yean Kit Fong
No Relationships to Disclose
 
Michael Hubank
Research Funding - Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Guardant Health; Guardant Health; Guardant Health; Guardant Health; Lilly; Lilly; Lilly; Lilly; Roche; Roche; Roche; Roche
 
Claire Saffery
No Relationships to Disclose
 
Eleftheria Kalaitzaki
No Relationships to Disclose
 
Kate Young
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Verastem (Inst); Verastem (Inst); Verastem (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Lilly; Lilly; Lilly; Lilly
 
Tracy Coyne
No Relationships to Disclose
 
Annette Musallam
No Relationships to Disclose
 
Nicos Fotiadis
No Relationships to Disclose
 
Andrew Wotherspoon
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene
Travel, Accommodations, Expenses - Pfizer; Pfizer; Pfizer; Pfizer
 
Ruwaida Begum
No Relationships to Disclose
 
Imene Zerizer
No Relationships to Disclose
 
Sheela Rao
Honoraria - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Incyte; Incyte; Incyte; Incyte; Roche Belgium; Roche Belgium; Roche Belgium; Roche Belgium; SERVIER; SERVIER; SERVIER; SERVIER
 
David J. Watkins
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen
 
Marco Gerlinger
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA
 
Irene Yu-Shing Chong
Research Funding - Janssen; Janssen; Janssen; Janssen; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA
 
Christopher J. Lord
Stock and Other Ownership Interests - Tango Therapeutics; Tango Therapeutics; Tango Therapeutics; Tango Therapeutics
Honoraria - Artios; Artios; Artios; Artios; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Gerson Lehrman Group; Gerson Lehrman Group; Gerson Lehrman Group; Gerson Lehrman Group; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Sun Pharma; Sun Pharma; Sun Pharma; Sun Pharma; Tango Therapeutics; Tango Therapeutics; Tango Therapeutics; Tango Therapeutics; Third Rock Ventures; Third Rock Ventures; Third Rock Ventures; Third Rock Ventures; Vertex; Vertex; Vertex; Vertex
Research Funding - Artios; Artios; Artios; Artios; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA
Patents, Royalties, Other Intellectual Property - ICR REWARDS TO INVENTORS; ICR REWARDS TO INVENTORS; ICR REWARDS TO INVENTORS; ICR REWARDS TO INVENTORS
 
Ian Chau
Honoraria - Lilly; Lilly; Lilly; Lilly
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; Lilly; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Oncologie; Oncologie; Oncologie; Oncologie; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
Research Funding - Janssen-Cilag (Inst); Janssen-Cilag (Inst); Janssen-Cilag (Inst); Janssen-Cilag (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; Lilly; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD; MSD; MSD; MSD
 
David Cunningham
Research Funding - 4SC (Inst); 4SC (Inst); 4SC (Inst); 4SC (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Janssen (Inst); Janssen (Inst); Janssen (Inst); Janssen (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merrimack (Inst); Merrimack (Inst); Merrimack (Inst); Merrimack (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst)
 
Naureen Starling
Honoraria - Lilly; Lilly; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; SERVIER; SERVIER; SERVIER; SERVIER
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Pfizer/EMD Serono (Inst); Pfizer/EMD Serono (Inst); Pfizer/EMD Serono (Inst); Pfizer/EMD Serono (Inst)
Travel, Accommodations, Expenses - MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology